Ping Wang

ORCID: 0009-0003-7813-6207
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lipoproteins and Cardiovascular Health
  • Hernia repair and management
  • Testicular diseases and treatments
  • Colorectal and Anal Carcinomas
  • Health Systems, Economic Evaluations, Quality of Life
  • Cancer, Lipids, and Metabolism
  • Genetic factors in colorectal cancer
  • Congenital Diaphragmatic Hernia Studies
  • Lung Cancer Treatments and Mutations
  • Colorectal Cancer Treatments and Studies
  • Pharmaceutical Economics and Policy
  • Urological Disorders and Treatments
  • Intestinal Malrotation and Obstruction Disorders
  • Frailty in Older Adults
  • Myasthenia Gravis and Thymoma
  • Gastric Cancer Management and Outcomes
  • Esophageal Cancer Research and Treatment
  • Esophageal and GI Pathology
  • Neurological and metabolic disorders
  • Pituitary Gland Disorders and Treatments
  • Urologic and reproductive health conditions
  • Genital Health and Disease
  • Adrenal and Paraganglionic Tumors
  • Elbow and Forearm Trauma Treatment
  • Autoimmune Bullous Skin Diseases

Dongyang People's Hospital
2023

University of California, San Francisco
2023

Hospital of Hebei Province
2023

Wenzhou Medical University
2023

West China Second University Hospital of Sichuan University
2020

Sichuan University
2020

Zhejiang University
2009-2018

Hangzhou First People's Hospital
2018

Jewish Hospital
2016-2017

Tianjin Medical University Cancer Institute and Hospital
2012

LDL cholesterol (LDLC) lowering has been revolutionized by PCSK9 inhibitors, Alirocumab (Praluent) and Evolocumab (Repatha), approved as adjuncts to maximally tolerated therapy in heterozygous (HeFH) or homozygous (HoFH) familial hypercholesterolemia, and/or clinical atherosclerotic cardiovascular disease (CVD) where LDLC is insufficient. We applied FDA insurance eligibility criteria for inhibitor use 734 hypercholesterolemic patients serially referred over 3 years who then received ≥ 2...

10.1186/s12944-016-0227-2 article EN cc-by Lipids in Health and Disease 2016-03-11

PCSK9 inhibitor therapy has been approved by the FDA as an adjunct to diet-maximal tolerated cholesterol lowering drug for adults with heterozygous familial hypercholesterolemia (HeFH) or clinical atherosclerotic cardiovascular disease (ASCVD) suboptimal LDL (LDLC) despite maximal diet-drug therapy. With estimated ~24million of US hypercholesterolemic patients potentially eligible inhibitors, costing ~ $14,300/patient/year, it is important assess health-care savings arising from inhibitors...

10.1186/s12944-016-0302-8 article EN cc-by Lipids in Health and Disease 2016-08-18

As two of the basic senses human beings, olfaction and gustation play a very important role in daily life. These types chemical sensors are for recognizing environmental conditions. Electronic nose electronic tongue, which mimics animals' to detect odors components, have been carried out due their potential commercial applications biomedicine, food industry protection. In this report, biomimetic artificial tongue is presented. Firstly, smell taste mimicking mammalian was described, then,...

10.1063/1.3156561 article EN AIP conference proceedings 2009-01-01

Proprotein convertase subtilisin/kexin type 9 inhibitors, Praluent (alirocumab [ALI]) and Repatha (evolocumab [EVO]) have been approved as adjuncts to the standard-of-care maximal-tolerated dose (MTD) of low-density lipoprotein cholesterol (LDLC)-lowering therapy (LLT), statin therapy, in heterozygous (HeFH) (ALI or EVO) homozygous (EVO) familial hypercholesterolemia, clinical atherosclerotic cardiovascular disease (CVD) where LDLC lowering is insufficient (both). Since has revolutionized by...

10.2147/vhrm.s133690 article EN cc-by-nc Vascular Health and Risk Management 2017-07-01

Primary signet ring cell carcinoma of the colorectum is rarely detected at an early stage,here,we present a case with stage primary colon, and patient was treated stage, prognosis well. We also provide endoscopic histological characteristics SRCC.

10.17235/reed.2023.10016/2023 article EN publisher-specific-oa Revista Española de Enfermedades Digestivas 2023-01-01

10.3969/j.issn.1000-8179.2010.15.016 article EN Clinical Oncology and Cancer Research 2010-08-15

Adjuvant and neoadjuvant therapy are the important therapeutic methods for rectal cancer.Neoadjuvant concurrent chemoradiotherapy postoperative adjuvant chemotherapy play a crutial role in cancer treatment.New drugs targeted could further improve effect of cancer. Key words: Rectal neoplasms ;  Radiotherapy Drug Therapy Targeting

10.3760/cma.j.issn.1673-422x.2012.011.020 article EN Guoji zhongliuxue zazhi 2012-11-08

Recurrent intussusception is one of the common acute abdominal diseases in infants, which seriously affects physical and mental health but its risk factors have not been fully clarified. The objective this study was to evaluate relationship between Th2/Th1 cytokine imbalance recurrent intussusception, so as provide a theoretical basis for making more comprehensive treatment strategy patients with intussusception. A retrospective conducted July 2012 September 2022, enrolling Children's...

10.1097/md.0000000000033391 article EN cc-by-nc Medicine 2023-03-31

The main goal of the guidelines is to improve patients' outcome, specifically decrease recurrence rates and reduce chronic pain. 136 statements 88 recommendations were discussed by expert group this guideline. part one guideline discusses 15 questions related management inguinal hernias in adults. Among them, Chinese interpretation 10 has been published last volume. two discuses 6 questions, No. 16~No.21. This article summarizes following key points guideline: (1) Groin women; (2) Femoral...

10.3877/cma.j.issn.1674-392x.2018.06.001 article EN Chin J Hernia Abdominal Wall Surg(Electronic Edition) 2018-12-18

10.3877/cma.j.issn.1674-392x.2019.06.002 article EN Chin J Hernia Abdominal Wall Surg(Electronic Edition) 2019-12-18

Objective To explore the anatomic basis for and clinical outcomes of internal fixation which preserves pronator quadratus (PQ) distal radius fractures. Methods Twenty cadaveric specimens adult upper extremity were used this study (14 males 6 females). The radial ulnar lengths PQ, proximal widths distances from end PQ to articular surface transverse line wrist, width bony tunnel dissected measured anatomical features PQ. A retrospective was conducted 18 fractures had been treated March...

10.3760/cma.j.issn.1671-7600.2018.05.002 article EN Zhonghua chuangshang guke zazhi 2018-05-15
Coming Soon ...